Cargando…

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017–2018

BACKGROUND: At present, because of indirect effects derived from routine childhood immunisation, clinical benefits vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPsV23) and/or the 13-valent pneumococcal conjugate vaccine (PCV13) are uncertain. This study investigated cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vila-Córcoles, Angel, Ochoa-Gondar, Olga, de Diego-Cabanes, Cinta, Satué-Gracia, Eva M., Torras-Vives, Verónica, Forcadell-Peris, M. José, Ribas-Seguí, Domingo, Vila-Rovira, Angel, Rodríguez-Casado, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Regular paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926188/ https://www.ncbi.nlm.nih.gov/pubmed/36798107 http://dx.doi.org/10.1016/j.jvacx.2023.100264

Ejemplares similares

Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study
por: Ochoa-Gondar, Olga, et al.
Publicado: (2023)

Epidemiología de la neumonía neumocócica en adultos mayores de 50 años: estudio de cohortes en Cataluña, 2017-2018
por: Ochoa-Gondar, Olga, et al.
Publicado: (2023)

Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017
por: Vila-Córcoles, Angel, et al.
Publicado: (2019)

Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings
por: Vila-Corcoles, Angel, et al.
Publicado: (2021)

COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March–June 2020
por: Vila-Corcoles, Angel, et al.
Publicado: (2021)

Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study
por: Vila-Corcoles, Angel, et al.
Publicado: (2018)

Vacunación antineumocócica en adultos de Cataluña: coberturas y grado de adecuación a distintas guías de recomendaciones
por: Ochoa-Gondar, Olga, et al.
Publicado: (2018)

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up
por: Vila-Corcoles, Angel, et al.
Publicado: (2012)

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain
por: Satué-Gracia, Eva M., et al.
Publicado: (2022)

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain
por: Satué-Gracia, Eva M., et al.
Publicado: (2022)

Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain
por: Vila-Córcoles, Angel, et al.
Publicado: (2020)

Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older
por: Vila-Corcoles, Angel, et al.
Publicado: (2010)

Enfermedad neumocócica en el adulto: niveles de riesgo y recomendaciones de vacunación
por: Vila-Córcoles, Angel, et al.
Publicado: (2017)

Utilidad de la escala de severidad modificada CRB75 en el manejo del paciente anciano con neumonía adquirida en la comunidad()
por: Ochoa Gondar, Olga, et al.
Publicado: (2013)

Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study
por: Ochoa-Gondar, O., et al.
Publicado: (2017)

Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up
por: Vila-Córcoles, Angel, et al.
Publicado: (2006)

Indicadores pronósticos de la COVID-19 en atención primaria
por: Satué Gracia, Eva María, et al.
Publicado: (2022)

Pneumococcal vaccination in times of COVID-19()
por: Vila Córcoles, Ángel
Publicado: (2022)

The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study
por: Ochoa-Gondar, Olga, et al.
Publicado: (2008)

Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia
por: Vila-Corcoles, Angel, et al.
Publicado: (2009)

Vacunación antineumocócica en tiempos de COVID-19
por: Vila Córcoles, Ángel
Publicado: (2022)

Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden
por: Galanis, Ilias, et al.
Publicado: (2016)

Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
por: Ludwig, Guillermo, et al.
Publicado: (2020)

Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain
por: Ciruela, Pilar, et al.
Publicado: (2022)

1180. Comparing Changes in Pneumococcal Meningitis Incidence to all Invasive Pneumococcal Disease Following Introduction of PCV10 and PCV13: The PSERENADE Project
por: Yang, Yangyupei, et al.
Publicado: (2021)

Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia
por: Roca, Anna, et al.
Publicado: (2015)

Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
por: Izquierdo, C., et al.
Publicado: (2020)

Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany
por: van der Linden, Mark, et al.
Publicado: (2016)

Estimation of the prevalence of thyroid dysfunction in Catalonia through two different registries: Pharmaceutical dispensing and diagnostic registration
por: Torrejón, Sara, et al.
Publicado: (2020)

Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009–June 2015
por: Regev-Yochay, Gili, et al.
Publicado: (2018)

Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced
por: Chang, Qiuzhi, et al.
Publicado: (2015)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
por: Perdrizet, Johnna, et al.
Publicado: (2020)

Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain
por: del Amo, Eva, et al.
Publicado: (2016)

2703. Pneumococcal Carriage of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Non-PCV13 Serotypes among Greek Children Vaccinated with PCV13 in a 3 + 1 Schedule During the First 6 years after the Fourth Dose of PCV13
por: Syrogiannopoulos, George A, et al.
Publicado: (2019)

Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy
por: Ansaldi, Filippo, et al.
Publicado: (2020)

1735. Impact of Children Universal Pneumococcal Vaccination (PCV7v/PCV13v) on Pneumococcal Invasive Disease Hospitalizations in a Private General Hospital, Uruguay
por: Sanchez-Varela, Mercecedes, et al.
Publicado: (2023)

Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13
por: Redin, A., et al.
Publicado: (2021)

Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study
por: Palà, Elena, et al.
Publicado: (2022)

1480. Incidence of Non-Invasive Pneumococcal Pneumonia in Children in the United States before and after Introduction Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
por: Hu, Tianyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nf4s4fph0gqhveohc4f8vls7d0